In the news

Teva says its MS drug works after Biogen fails

May 31, 2006

Dr. Omar Khan, associate professor of neurology at Wayne State and senior author of this study on the multiple sclerosis drug Copaxone, said the results of the study suggest that observation of relapse rates, patient tolerability and toxicity assessment are important variables in determining whether or not the drug should be used.